The Series Podcast Objectives are:
Podcast objectives include understanding how the medical affairs strategic planning process can drive decision making throughout the year
The Medical Affairs Professional Society (MAPS) is honored to announce the inclusion of Johnson and Johnson Pharmaceuticals (JNJ) in the MAPS Industry Partnership Program
Amgen’s Victoria Elegant and Ka Weng Mah had front row seats to the start of COVID-19 in Asia. Here is what they learned about the future of Medical Affairs.
Medical Affairs thought leaders discuss the function, activities and opportunities for compliant collaboration with key internal partners.
Q&A with Medical Affairs thought leaders describing changes in Digital and Field Medical during the pandemic and beyond
This webinar describes the NeuroLeadership Institute’s SCARF model (Status, Certainty, Autonomy, Relatedness, Fairness) and its application to the practice of Medical Affairs
Nothing could stand between Joseph Eid and his dream of becoming a doctor—not even gunfire.
Cerise James, MD, moderates this podcast in which Neil Belson, JD, discusses Real World Evidence and its impact to the biopharmaceutical industry.
Real-World Evidence can show safety and effectiveness per FDA’s “totality of evidence approach” for evaluating regulatory submissions.
This Medical Affairs Professional Society (MAPS) podcast features medical affairs thought leaders offering insights into the Medical Affairs strategic planning process